Showing results (61-70 of 77) with videos related to
Sort By:
Pageof 8
Molecular Cancer Research : MCR|October 26, 2018
PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type MelanomasKristen S Hill, Evan R Roberts, Xue Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2024
Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced MelanomaAhmad A Tarhini, Zeynep Eroglu, Islam Eljilany, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for ImmunotherapyJiannong Li, Inna Smalley, Zhihua Chen, et al.Annals of Surgical Oncology|October 14, 2021
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional ExperienceMichael J Carr, James Sun, Danielle DePalo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic MelanomaMacLean S Hall, John E Mullinax, Cheryl A Cox, et al.Annals of Surgical Oncology|October 31, 2025
Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node BiopsyMichelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin, et al.Journal for Immunotherapy of Cancer|October 6, 2023
Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patientsMacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2021
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic MelanomaAmod A Sarnaik, Omid Hamid, Nikhil I Khushalani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2022
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic MelanomaCaitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, et al.Nature Medicine|August 13, 2021
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trialBenjamin C Creelan, Chao Wang, Jamie K Teer, et al.Pageof 8